Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 131 participants.
Also called NCT04158076
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 131 participants
- Sponsor
- Registry
-
NCT04158076
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT04158076. Randomized; double masking; primary purpose treatment. Start 2020-01-23 (actual); primary completion 2021-01-14 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine
- Condition
- Hypercholesterolemia
- Condition
- Hypertension
- Intervention (Drug)
- Ezetimibe/Rosuvastatin
- Intervention (Drug)
- Telmisartan
- Intervention (Drug)
- Telmisartan/Amlodipine 80 Mg-5 Mg ORAL TABLET
- Lead sponsor
- Addpharma Inc.
Record details
- Record id
cardio:ct-nct04158076- Content hash
8d15419e5d11aa46b3fba65ab660506fdf3706b4a3e149a10435301e3fa92907